0001567619-15-001060.txt : 20150805
0001567619-15-001060.hdr.sgml : 20150805
20150805211202
ACCESSION NUMBER: 0001567619-15-001060
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150804
FILED AS OF DATE: 20150805
DATE AS OF CHANGE: 20150805
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: vTv Therapeutics Inc.
CENTRAL INDEX KEY: 0001641489
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473916571
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4170 MENDENHALL OAKS PKWY
CITY: HIGH POINT
STATE: NC
ZIP: 27265
BUSINESS PHONE: 336-841-0300
MAIL ADDRESS:
STREET 1: 4170 MENDENHALL OAKS PKWY
CITY: HIGH POINT
STATE: NC
ZIP: 27265
FORMER COMPANY:
FORMER CONFORMED NAME: VTV Therapeutics Inc.
DATE OF NAME CHANGE: 20150506
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PERELMAN RONALD O
CENTRAL INDEX KEY: 0001186472
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37524
FILM NUMBER: 151030792
MAIL ADDRESS:
STREET 1: 35 EAST 62ND STREET
CITY: NEW YORK
STATE: NY
ZIP: 10021
4
1
s000988x7_form4.xml
OWNERSHIP DOCUMENT
X0306
4
2015-08-04
0
0001641489
vTv Therapeutics Inc.
VTVT
0001186472
PERELMAN RONALD O
C/O MACANDREWS & FORBES INCORPORATED
35 EAST 62ND STREET
NEW YORK
NY
10065
0
0
1
0
Class A common stock
2015-08-04
4
P
0
40000
10.0021
A
1706666
I
See footnote.
Class A common stock
2015-08-04
4
P
0
30000
10.00
A
1736666
I
See footnote.
Class A common stock
2015-08-05
4
P
0
30000
9.9979
A
1766666
I
See footnote.
The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $9.99 to $10.05, inclusive, on August 3, 2015, prior to the closing of the Issuer's initial public offering. The reporting person undertakes to provide to vTv Therapeutics Inc., any security holder of vTv Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in footnotes 1 and 3 to this Form 4.
Mr. Ronald O. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"), which holds the securities described above. Mr. Perelman, M&F Inc., M&F LLC and M&F Group may be deemed to be directors by deputization of the Issuer by virtue of their relationship with Steven M. Cohen, Paul M. Meister and Paul G. Savas, directors of the Issuer, and certain rights of vTv Therapeutics Holdings LLC, an indirect subsidiary of M&F Inc. ("Holdings"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and Holdings.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.86 to $10.00, inclusive.
/s/ Barry F. Schwartz, attorney-in-fact
2015-08-05